{"entity":{"type":"insider","cik":"0001763592","url":"/insider/0001763592","json_url":"/insider/0001763592.json","name":"Wesche Holger","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2020-01-06","last":"2021-07-06","span_basis":"filed_date"},"name_variants":[{"name":"Wesche Holger","source":"filing","n_filings":9,"first_seen":"2020-01-06","last_seen":"2021-07-06"}],"transactions":[{"id":4622755,"accession":"0001209191-21-045618","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-045618","line_url":"/filing/0001209191-21-045618#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":52852.0,"shares_owned_after_display":"52,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider"},{"id":4619646,"accession":"0001209191-21-025203","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-025203","line_url":"/filing/0001209191-21-025203","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.449065,"price_display":"20.45","price_state":"stated","total_value":204490.65,"total_display":"204,490.65","total_whole":"204,491","shares_owned_after":53352.0,"shares_owned_after_display":"53,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider","n_lines":2},{"id":4656948,"accession":"0001209191-21-002317","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-002317","line_url":"/filing/0001209191-21-002317","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.38368825,"price_display":"18.38","price_state":"stated","total_value":183836.8825,"total_display":"183,836.88","total_whole":"183,837","shares_owned_after":52852.0,"shares_owned_after_display":"52,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":3},{"id":2119732,"accession":"0001209191-20-053596","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-053596","line_url":"/filing/0001209191-20-053596","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.27372,"price_display":"16.27","price_state":"stated","total_value":162737.2,"total_display":"162,737.20","total_whole":"162,737","shares_owned_after":53669.0,"shares_owned_after_display":"53,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider","n_lines":2},{"id":2292192,"accession":"0001209191-20-040695","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-040695","line_url":"/filing/0001209191-20-040695#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.1989,"price_display":"16.20","price_state":"stated","total_value":161989.0,"total_display":"161,989.00","total_whole":"161,989","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2898186,"accession":"0001209191-20-029020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-029020","line_url":"/filing/0001209191-20-029020#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":14.0857,"price_display":"14.09","price_state":"stated","total_value":19719.98,"total_display":"19,719.98","total_whole":"19,720","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"},{"id":2369429,"accession":"0001209191-20-028407","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-028407","line_url":"/filing/0001209191-20-028407#line-6","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":14.0651,"price_display":"14.07","price_state":"stated","total_value":14065.1,"total_display":"14,065.10","total_whole":"14,065","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-11","scope":"insider"},{"id":2369423,"accession":"0001209191-20-028407","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-028407","line_url":"/filing/0001209191-20-028407#line-4","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":14000.0,"total_display":"14,000.00","total_whole":"14,000","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-11","scope":"insider"},{"id":2369418,"accession":"0001209191-20-028407","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-028407","line_url":"/filing/0001209191-20-028407#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5350.0,"shares_display":"5,350","price_per_share":14.1263,"price_display":"14.13","price_state":"stated","total_value":75575.705,"total_display":"75,575.70","total_whole":"75,576","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider"},{"id":2897670,"accession":"0001209191-20-026337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-026337","line_url":"/filing/0001209191-20-026337#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":14.052,"price_display":"14.05","price_state":"stated","total_value":17565.0,"total_display":"17,565.00","total_whole":"17,565","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-28","filed_date":"2020-04-30","scope":"insider"},{"id":3233241,"accession":"0001209191-20-002180","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002180","line_url":"/filing/0001209191-20-002180#line-2","is_derivative":false,"issuer_cik":"0001708493","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001708493","owner_cik":"0001763592","owner_name":"Wesche Holger","owner_display_name":"Wesche Holger","owner_url":"/insider/0001763592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.3987,"price_display":"14.40","price_state":"stated","total_value":143987.0,"total_display":"143,987.00","total_whole":"143,987","shares_owned_after":52669.0,"shares_owned_after_display":"52,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Officer (Chief Scientific Officer)","n_filings":9,"first_seen":"2020-01-06","last_seen":"2021-07-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001763592","retrieved_at":"2026-08-26T18:19:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}